Balaxi Pharmaceuticals Ltd Results

Balaxi Pharmaceuticals Ltd’s revenue fell -5.94% since last year same period to ₹72.64Cr in the Q3 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 25.76% jump in its revenue since last 3-months.

Balaxi Pharmaceuticals Ltd’s net profit fell -94.22% since last year same period to ₹0.31Cr in the Q3 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 47.62% jump in its net profits since last 3-months.

Balaxi Pharmaceuticals Ltd’s net profit margin fell -93.85% since last year same period to 0.43% in the Q3 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 17.38% jumped in its net profit margins since last 3-months.